Aktienkurs

Dato	Cochlear Omsætning	Cochlear EBIT	Cochlear Indtjening
2029e	3,46 mia. undefined	0 undefined	667,43 mio. undefined
2028e	3,13 mia. undefined	776,23 mio. undefined	593,05 mio. undefined
2027e	2,86 mia. undefined	727,96 mio. undefined	556,45 mio. undefined
2026e	2,73 mia. undefined	672,69 mio. undefined	509,38 mio. undefined
2025e	2,52 mia. undefined	600,41 mio. undefined	455,06 mio. undefined
2024e	2,30 mia. undefined	527,40 mio. undefined	397,99 mio. undefined
2023	1,94 mia. undefined	411,60 mio. undefined	300,60 mio. undefined
2022	1,65 mia. undefined	394,00 mio. undefined	289,10 mio. undefined
2021	1,50 mia. undefined	355,90 mio. undefined	326,50 mio. undefined
2020	1,32 mia. undefined	241,00 mio. undefined	-238,30 mio. undefined
2019	1,43 mia. undefined	359,50 mio. undefined	276,70 mio. undefined
2018	1,36 mia. undefined	348,00 mio. undefined	245,80 mio. undefined
2017	1,25 mia. undefined	324,12 mio. undefined	223,62 mio. undefined
2016	1,13 mia. undefined	270,20 mio. undefined	188,92 mio. undefined
2015	925,63 mio. undefined	215,36 mio. undefined	145,84 mio. undefined
2014	804,90 mio. undefined	154,30 mio. undefined	93,70 mio. undefined
2013	752,70 mio. undefined	182,90 mio. undefined	132,60 mio. undefined
2012	779,00 mio. undefined	220,50 mio. undefined	56,80 mio. undefined
2011	809,60 mio. undefined	246,90 mio. undefined	180,10 mio. undefined
2010	734,80 mio. undefined	225,50 mio. undefined	155,20 mio. undefined
2009	694,70 mio. undefined	177,10 mio. undefined	130,50 mio. undefined
2008	601,70 mio. undefined	165,00 mio. undefined	115,20 mio. undefined
2007	559,40 mio. undefined	153,60 mio. undefined	100,10 mio. undefined
2006	452,30 mio. undefined	108,50 mio. undefined	80,00 mio. undefined
2005	348,50 mio. undefined	80,00 mio. undefined	54,50 mio. undefined
2004	285,80 mio. undefined	52,30 mio. undefined	36,80 mio. undefined

	Omsætning	EBIT	Indtjening
2004	285,80 mio. AUD	52,30 mio. AUD	36,80 mio. AUD
2005	348,50 mio. AUD	80,00 mio. AUD	54,50 mio. AUD
2006	452,30 mio. AUD	108,50 mio. AUD	80,00 mio. AUD
2007	559,40 mio. AUD	153,60 mio. AUD	100,10 mio. AUD
2008	601,70 mio. AUD	165,00 mio. AUD	115,20 mio. AUD
2009	694,70 mio. AUD	177,10 mio. AUD	130,50 mio. AUD
2010	734,80 mio. AUD	225,50 mio. AUD	155,20 mio. AUD
2011	809,60 mio. AUD	246,90 mio. AUD	180,10 mio. AUD
2012	779,00 mio. AUD	220,50 mio. AUD	56,80 mio. AUD
2013	752,70 mio. AUD	182,90 mio. AUD	132,60 mio. AUD
2014	804,90 mio. AUD	154,30 mio. AUD	93,70 mio. AUD
2015	925,63 mio. AUD	215,36 mio. AUD	145,84 mio. AUD
2016	1,13 mia. AUD	270,20 mio. AUD	188,92 mio. AUD
2017	1,25 mia. AUD	324,12 mio. AUD	223,62 mio. AUD
2018	1,36 mia. AUD	348,00 mio. AUD	245,80 mio. AUD
2019	1,43 mia. AUD	359,50 mio. AUD	276,70 mio. AUD
2020	1,32 mia. AUD	241,00 mio. AUD	-238,30 mio. AUD
2021	1,50 mia. AUD	355,90 mio. AUD	326,50 mio. AUD
2022	1,65 mia. AUD	394,00 mio. AUD	289,10 mio. AUD
2023	1,94 mia. AUD	411,60 mio. AUD	300,60 mio. AUD
2024e	2,30 mia. AUD	527,40 mio. AUD	397,99 mio. AUD
2025e	2,52 mia. AUD	600,41 mio. AUD	455,06 mio. AUD
2026e	2,73 mia. AUD	672,69 mio. AUD	509,38 mio. AUD
2027e	2,86 mia. AUD	727,96 mio. AUD	556,45 mio. AUD
2028e	3,13 mia. AUD	776,23 mio. AUD	593,05 mio. AUD
2029e	3,46 mia. AUD	0 AUD	667,43 mio. AUD

Cochlear Bruttomargin	Cochlear Overskudsmargen	Cochlear EBIT-margin	Cochlear Overskudsmargen
2029e	75,07 %	0 %	19,30 %
2028e	75,07 %	24,78 %	18,94 %
2027e	75,07 %	25,44 %	19,45 %
2026e	75,07 %	24,67 %	18,68 %
2025e	75,07 %	23,83 %	18,06 %
2024e	75,07 %	22,94 %	17,31 %
2023	75,07 %	21,26 %	15,53 %
2022	75,86 %	23,90 %	17,54 %
2021	73,38 %	23,76 %	21,80 %
2020	74,54 %	18,25 %	-18,04 %
2019	75,85 %	25,20 %	19,39 %
2018	73,72 %	25,52 %	18,02 %
2017	71,94 %	25,85 %	17,83 %
2016	71,93 %	23,90 %	16,71 %
2015	71,35 %	23,27 %	15,76 %
2014	69,35 %	19,17 %	11,64 %
2013	72,55 %	24,30 %	17,62 %
2012	74,53 %	28,31 %	7,29 %
2011	72,62 %	30,50 %	22,25 %
2010	73,31 %	30,69 %	21,12 %
2009	72,12 %	25,49 %	18,79 %
2008	72,31 %	27,42 %	19,15 %
2007	71,17 %	27,46 %	17,89 %
2006	71,04 %	23,99 %	17,69 %
2005	73,80 %	22,96 %	15,64 %
2004	73,44 %	18,30 %	12,88 %

	Bruttomargin	EBIT-margin	Overskudsmargen
2004	73,44 %	18,30 %	12,88 %
2005	73,80 %	22,96 %	15,64 %
2006	71,04 %	23,99 %	17,69 %
2007	71,17 %	27,46 %	17,89 %
2008	72,31 %	27,42 %	19,15 %
2009	72,12 %	25,49 %	18,79 %
2010	73,31 %	30,69 %	21,12 %
2011	72,62 %	30,50 %	22,25 %
2012	74,53 %	28,31 %	7,29 %
2013	72,55 %	24,30 %	17,62 %
2014	69,35 %	19,17 %	11,64 %
2015	71,35 %	23,27 %	15,76 %
2016	71,93 %	23,90 %	16,71 %
2017	71,94 %	25,85 %	17,83 %
2018	73,72 %	25,52 %	18,02 %
2019	75,85 %	25,20 %	19,39 %
2020	74,54 %	18,25 %	-18,04 %
2021	73,38 %	23,76 %	21,80 %
2022	75,86 %	23,90 %	17,54 %
2023	75,07 %	21,26 %	15,53 %
2024e	75,07 %	22,94 %	17,31 %
2025e	75,07 %	23,83 %	18,06 %
2026e	75,07 %	24,67 %	18,68 %
2027e	75,07 %	25,44 %	19,45 %
2028e	75,07 %	24,78 %	18,94 %
2029e	75,07 %	0 %	19,30 %

Dato	Cochlear Omsætning per aktie	Cochlear EBIT per aktie	Cochlear Indtjening per aktie
2029e	52,81 undefined	0 undefined	10,19 undefined
2028e	47,82 undefined	0 undefined	9,06 undefined
2027e	43,68 undefined	0 undefined	8,50 undefined
2026e	41,64 undefined	0 undefined	7,78 undefined
2025e	38,48 undefined	0 undefined	6,95 undefined
2024e	35,10 undefined	0 undefined	6,08 undefined
2023	29,38 undefined	6,25 undefined	4,56 undefined
2022	25,06 undefined	5,99 undefined	4,40 undefined
2021	22,78 undefined	5,41 undefined	4,97 undefined
2020	22,14 undefined	4,04 undefined	-4,00 undefined
2019	24,72 undefined	6,23 undefined	4,79 undefined
2018	23,67 undefined	6,04 undefined	4,27 undefined
2017	21,82 undefined	5,64 undefined	3,89 undefined
2016	19,75 undefined	4,72 undefined	3,30 undefined
2015	16,17 undefined	3,76 undefined	2,55 undefined
2014	14,10 undefined	2,70 undefined	1,64 undefined
2013	13,21 undefined	3,21 undefined	2,33 undefined
2012	13,69 undefined	3,88 undefined	1,00 undefined
2011	14,20 undefined	4,33 undefined	3,16 undefined
2010	12,98 undefined	3,98 undefined	2,74 undefined
2009	12,41 undefined	3,16 undefined	2,33 undefined
2008	10,78 undefined	2,96 undefined	2,06 undefined
2007	10,06 undefined	2,76 undefined	1,80 undefined
2006	8,21 undefined	1,97 undefined	1,45 undefined
2005	6,42 undefined	1,47 undefined	1,00 undefined
2004	5,30 undefined	0,97 undefined	0,68 undefined

	Omsætning per aktie	EBIT per aktie	Indtjening per aktie
2004	5,30 AUD	0,97 AUD	0,68 AUD
2005	6,42 AUD	1,47 AUD	1,00 AUD
2006	8,21 AUD	1,97 AUD	1,45 AUD
2007	10,06 AUD	2,76 AUD	1,80 AUD
2008	10,78 AUD	2,96 AUD	2,06 AUD
2009	12,41 AUD	3,16 AUD	2,33 AUD
2010	12,98 AUD	3,98 AUD	2,74 AUD
2011	14,20 AUD	4,33 AUD	3,16 AUD
2012	13,69 AUD	3,88 AUD	1,00 AUD
2013	13,21 AUD	3,21 AUD	2,33 AUD
2014	14,10 AUD	2,70 AUD	1,64 AUD
2015	16,17 AUD	3,76 AUD	2,55 AUD
2016	19,75 AUD	4,72 AUD	3,30 AUD
2017	21,82 AUD	5,64 AUD	3,89 AUD
2018	23,67 AUD	6,04 AUD	4,27 AUD
2019	24,72 AUD	6,23 AUD	4,79 AUD
2020	22,14 AUD	4,04 AUD	-4,00 AUD
2021	22,78 AUD	5,41 AUD	4,97 AUD
2022	25,06 AUD	5,99 AUD	4,40 AUD
2023	29,38 AUD	6,25 AUD	4,56 AUD
2024e	35,10 AUD	0 AUD	6,08 AUD
2025e	38,48 AUD	0 AUD	6,95 AUD
2026e	41,64 AUD	0 AUD	7,78 AUD
2027e	43,68 AUD	0 AUD	8,50 AUD
2028e	47,82 AUD	0 AUD	9,06 AUD
2029e	52,81 AUD	0 AUD	10,19 AUD

	Antal aktier
2004	53,90 mio. Aktien
2005	54,30 mio. Aktien
2006	55,10 mio. Aktien
2007	55,60 mio. Aktien
2008	55,80 mio. Aktien
2009	56,00 mio. Aktien
2010	56,60 mio. Aktien
2011	57,00 mio. Aktien
2012	56,90 mio. Aktien
2013	57,00 mio. Aktien
2014	57,10 mio. Aktien
2015	57,23 mio. Aktien
2016	57,24 mio. Aktien
2017	57,47 mio. Aktien
2018	57,60 mio. Aktien
2019	57,71 mio. Aktien
2020	59,63 mio. Aktien
2021	65,73 mio. Aktien
2022	65,77 mio. Aktien
2023	65,90 mio. Aktien
2024e	65,90 mio. Aktien
2025e	65,90 mio. Aktien
2026e	65,90 mio. Aktien
2027e	65,90 mio. Aktien
2028e	65,90 mio. Aktien
2029e	65,90 mio. Aktien

Dato	Cochlear Udbytte
2029e	4,26 undefined
2028e	4,26 undefined
2027e	4,27 undefined
2026e	4,26 undefined
2025e	4,25 undefined
2024e	4,29 undefined
2023	4,06 undefined
2022	3,25 undefined
2021	2,55 undefined
2020	2,29 undefined
2019	4,71 undefined
2018	4,29 undefined
2017	3,86 undefined
2016	3,29 undefined
2015	2,46 undefined
2014	2,65 undefined
2013	2,90 undefined
2012	2,95 undefined
2011	2,88 undefined
2010	2,68 undefined
2009	2,50 undefined
2008	2,14 undefined
2007	1,79 undefined
2006	1,43 undefined
2005	1,14 undefined
2004	1,13 undefined

	Udbytte	Udbytte (estimat)
2004	1,13 AUD	0 AUD
2005	1,14 AUD	0 AUD
2006	1,43 AUD	0 AUD
2007	1,79 AUD	0 AUD
2008	2,14 AUD	0 AUD
2009	2,50 AUD	0 AUD
2010	2,68 AUD	0 AUD
2011	2,88 AUD	0 AUD
2012	2,95 AUD	0 AUD
2013	2,90 AUD	0 AUD
2014	2,65 AUD	0 AUD
2015	2,46 AUD	0 AUD
2016	3,29 AUD	0 AUD
2017	3,86 AUD	0 AUD
2018	4,29 AUD	0 AUD
2019	4,71 AUD	0 AUD
2020	2,29 AUD	0 AUD
2021	2,55 AUD	0 AUD
2022	3,25 AUD	0 AUD
2023	4,06 AUD	0 AUD
2024e	0 AUD	4,29 AUD
2025e	0 AUD	4,25 AUD
2026e	0 AUD	4,26 AUD
2027e	0 AUD	4,27 AUD
2028e	0 AUD	4,26 AUD
2029e	0 AUD	4,26 AUD

Dato	Cochlear Udbetalingsrate
2029e	70,48 %
2028e	70,78 %
2027e	69,73 %
2026e	70,93 %
2025e	71,67 %
2024e	66,59 %
2023	74,52 %
2022	73,91 %
2021	51,34 %
2020	-57,20 %
2019	98,32 %
2018	100,60 %
2017	99,12 %
2016	99,56 %
2015	96,67 %
2014	161,52 %
2013	124,90 %
2012	294,71 %
2011	91,14 %
2010	97,71 %
2009	107,30 %
2008	103,52 %
2007	99,21 %
2006	98,52 %
2005	114,29 %
2004	165,97 %

	Udbetalingsrate
2004	165,97 %
2005	114,29 %
2006	98,52 %
2007	99,21 %
2008	103,52 %
2009	107,30 %
2010	97,71 %
2011	91,14 %
2012	294,71 %
2013	124,90 %
2014	161,52 %
2015	96,67 %
2016	99,56 %
2017	99,12 %
2018	100,60 %
2019	98,32 %
2020	-57,20 %
2021	51,34 %
2022	73,91 %
2023	74,52 %
2024e	66,59 %
2025e	71,67 %
2026e	70,93 %
2027e	69,73 %
2028e	70,78 %
2029e	70,48 %

Dato	EPS-estimat	EPS-Actual	Regnskabskvartal
31.12.2023	2,91	2,92 (0,45 %)	2024 Q2
30.6.2023	2,46	2,48 (0,73 %)	2023 Q4
31.12.2022	2,02	2,15 (6,35 %)	2023 Q2
30.6.2022	1,94	1,82 (-6,11 %)	2022 Q4
31.12.2021	1,99	2,40 (20,09 %)	2022 Q2
30.6.2021	1,79	1,70 (-5,46 %)	2021 Q4
31.12.2020	1,46	1,91 (30,59 %)	2021 Q2
30.6.2020	0,36	0,28 (-20,71 %)	2020 Q4
31.12.2019	2,53	2,30 (-9,07 %)	2020 Q2
30.6.2019	2,47	2,57 (4,00 %)	2019 Q4
31.12.2018	2,22	2,23 (0,59 %)	2019 Q2
30.6.2018	2,39	2,34 (-1,96 %)	2018 Q4
30.6.2017	1,98	1,95 (-1,39 %)	2017 Q4
30.6.2016	1,74	1,66 (-4,67 %)	2016 Q4
31.12.2015	1,56	1,64 (5,70 %)	2016 Q2
31.12.2014	1,38	1,25 (-9,73 %)	2015 Q2
30.6.2014	1,17	1,28 (8,91 %)	2014 Q4
31.12.2013	0,86	0,65 (-25,01 %)	2014 Q2
30.6.2013	0,99	0,96 (-2,54 %)	2013 Q4
31.12.2012	1,37	1,36 (-0,42 %)	2013 Q2
30.6.2012	1,56	1,37 (-12,38 %)	2012 Q4
31.12.2011	1,24	1,41 (13,34 %)	2012 Q2
30.6.2011	1,56	1,63 (4,67 %)	2011 Q4

%	Navn	Aktier	Ændring	Dato
5,52 %	APG Asset Management N.V.	3.618.341	-4.781	29.7.2022
5,01 %	The Vanguard Group, Inc.	3.282.658	1.434.494	27.9.2023
4,95 %	Pinnacle Investment Management Group Ltd	3.239.726	-59.277	3.11.2023
2,08 %	BlackRock Institutional Trust Company, N.A.	1.360.567	1.463	31.3.2024
1,75 %	Norges Bank Investment Management (NBIM)	1.144.567	143.143	31.12.2023
1,75 %	Stewart Investors	1.144.269	3.520	30.9.2023
1,53 %	Vanguard Investments Australia Ltd.	1.003.485	142	29.2.2024
0,94 %	Schroder Investment Management (Singapore) Ltd.	618.276	-31.659	31.12.2023
0,75 %	Walter Scott & Partners Ltd.	490.700	0	29.2.2024
0,69 %	Commonwealth Superannuation Corporation	451.702	90.956	28.7.2023
0,67 %	Geode Capital Management, L.L.C.	439.118	-122	31.3.2024
0,64 %	BlackRock Advisors (UK) Limited	416.679	3.816	31.3.2024
0,59 %	BlackRock Investment Management (UK) Ltd.	387.320	-11.594	31.3.2024
0,59 %	BetaShares Capital Ltd.	384.157	1.932	31.3.2024
0,55 %	Aviva Investors Global Services Limited	357.643	1.625	31.3.2024
0,49 %	Australian Foundation Investment Company Ltd	324.174	0	28.7.2023
0,49 %	California State Teachers Retirement System	319.405	-15.665	30.6.2023
0,47 %	Netwealth Investments Ltd.	305.565	-62.037	28.7.2023
0,41 %	Invesco Advisers, Inc.	267.894	-1.787	29.2.2024
0,39 %	Colonial First State Investments Limited	253.816	82.323	28.7.2023
0,36 %	Nuveen LLC	237.732	-5.795	31.3.2024
0,35 %	MLC Asset Management	229.342	-7.238	31.12.2023
0,34 %	Charles Schwab Investment Management, Inc.	221.651	63	31.3.2024
0,33 %	Australian Ethical Investment Ltd.	216.345	216.345	31.12.2022
0,31 %	Franklin Equity Group	205.000	0	31.1.2024
0,31 %	abrdn Asia Limited	202.171	0	29.2.2024
0,30 %	BlackRock Investment Management (Australia) Ltd.	196.363	1.141	31.3.2024
0,29 %	Baillie Gifford & Co.	187.662	-3.802	29.2.2024
0,28 %	AllianceBernstein L.P.	181.622	1.538	29.2.2024
0,28 %	abrdn Investments Limited	180.743	-6.416	29.2.2024
0,28 %	JP Morgan Asset Management	180.136	995	31.3.2024
0,27 %	State Street Global Advisors Australia Ltd.	174.412	-338	31.3.2024
0,26 %	Florida State Board of Administration	173.278	-80.394	30.9.2022
0,26 %	Dimensional Fund Advisors, L.P.	173.198	942	31.3.2024
0,26 %	Roberts (Christopher Graham)	172.387	0	28.7.2023
0,26 %	Goldman Sachs Asset Management, L.P.	172.091	44	31.3.2024
0,26 %	Achmea Investment Management B.V.	167.519	-113	29.2.2024
0,25 %	Jupiter Asset Management Ltd.	161.361	60.596	31.12.2023
0,24 %	WCM Investment Management	155.922	-5.212	30.6.2023
0,24 %	Amundi Japan Ltd.	154.564	-7.323	31.3.2024
0,22 %	First Sentier Investments (U.K.) Ltd	143.383	0	30.9.2023
0,20 %	UBS Asset Management (UK) Ltd.	133.998	740	31.3.2024
0,20 %	DFA Australia Ltd.	132.495	517	31.12.2023
0,20 %	First Sentier Investors (Hong Kong) Limited	129.159	-11.370	30.9.2023
0,18 %	U Ethical	120.408	-324	30.11.2023
0,18 %	Bennelong Australian Equity Partners Pty. Ltd.	119.395	119.395	31.12.2023
0,18 %	State Street Global Advisors (UK) Ltd.	117.812	0	31.3.2024
0,16 %	VanEck Australia Pty Ltd.	107.118	-3.447	31.12.2023
0,15 %	Cochlear Incentive Plan Pty. Ltd.	101.003	40.894	28.7.2023
0,15 %	T. Rowe Price International Ltd	100.529	303	31.3.2024
0,15 %	Aberdeen Standard Investments (Edinburgh)	97.617	-466	29.2.2024
0,15 %	State Street Global Advisors (US)	97.315	1.860	31.3.2024
0,14 %	Legal & General Investment Management Ltd.	94.828	133	31.3.2024
0,13 %	Amundi Asset Management, SAS	83.959	7.680	31.3.2024
0,13 %	Schroder Investment Management Ltd. (SIM)	82.000	10.971	31.3.2024
0,11 %	BNP Paribas Asset Management France SAS	73.582	34.640	29.2.2024
0,11 %	Mellon Investments Corporation	73.518	14.233	31.3.2024
0,10 %	Credit Suisse Funds AG	64.191	-444	31.3.2024
0,09 %	PGGM Vermogensbeheer B.V.	62.183	30.071	31.7.2023
0,09 %	1832 Asset Management L.P.	60.382	0	31.12.2023
0,09 %	Goldman Sachs Asset Management B.V.	59.393	14.368	31.1.2024
0,09 %	Graubündner Kantonalbank	56.300	56.300	31.12.2023
0,08 %	Macquarie Investment Management	55.361	308	31.3.2024
0,08 %	Howitt (Diggory William)	54.073	279	12.3.2024
0,08 %	Federated Hermes International	53.896	278	31.3.2024
0,08 %	JPMorgan Asset Management U.K. Limited	52.200	894	31.3.2024
0,08 %	UBS Asset Management (Switzerland)	51.976	-321	29.2.2024
0,08 %	HSBC Global Asset Management (UK) Limited	51.400	6.351	29.2.2024
0,08 %	BlackRock Asset Management Canada Limited	50.652	-4.368	31.3.2024
0,08 %	Eurizon Capital SGR S.p.A.	49.955	-7.032	29.2.2024
0,07 %	DWS Investments UK Limited	46.570	-31	31.3.2024
0,07 %	Franklin Advisers, Inc.	44.253	-784	31.3.2024
0,06 %	Trillium Asset Management, LLC	41.938	-485	31.12.2023
0,06 %	Lazard Asset Management, L.L.C.	41.542	4.379	31.3.2024
0,06 %	T. Rowe Price Associates, Inc.	41.476	1.020	29.2.2024
0,06 %	Wellington Management Company, LLP	41.432	3.641	29.2.2024
0,06 %	MLC Investments Limited	41.287	-2.830	31.12.2023
0,06 %	Northern Trust Global Investments Limited	40.199	2.798	31.12.2023
0,06 %	M. Elsasser Vermögensverwaltung Wealth Management GmbH	38.000	0	30.6.2023
0,05 %	Cardano Asset Management NV	35.825	-3.486	29.2.2024
0,05 %	Bellevue Asset Management AG	33.894	-23.500	29.2.2024
0,05 %	M&G Investment Management Ltd.	33.574	148	31.12.2023
0,05 %	CPR Asset Management	30.995	-584	29.2.2024
0,05 %	Veritas Asset Management LLP	30.742	0	29.2.2024
0,05 %	DWS Investment GmbH	30.358	-419	31.3.2024
0,04 %	SEI Investments Management Corporation	28.742	10.978	31.3.2024
0,04 %	Schroder Investment Management (Hong Kong) Ltd.	28.199	0	31.12.2023
0,04 %	Eurizon Capital S.A.	27.950	-987	29.2.2024
0,04 %	Royal London Asset Management Ltd.	26.702	0	31.12.2023
0,04 %	Vanguard Global Advisers LLC	26.164	217	31.3.2024
0,04 %	abrdn Australia Limited	26.097	0	30.9.2022
0,04 %	William Blair Investment Management, LLC	25.500	0	29.2.2024
0,04 %	BlackRock Financial Management, Inc.	25.247	-131	29.2.2024
0,04 %	Schroder Investment Management (Japan) Ltd.	25.224	-34	30.6.2023
0,04 %	American Century Investment Management, Inc.	24.080	4.710	31.3.2024
0,04 %	Mackenzie Financial Corporation	23.125	-12.536	31.3.2024
0,03 %	KLP Fondsforvaltning AS	22.459	0	29.2.2024
0,03 %	BNP Paribas Asset Management Nederland N.V.	22.366	-1.941	31.3.2024
0,03 %	DBX Advisors LLC.	22.312	1.102	29.2.2024
0,03 %	Manulife Investment Management (North America) Limited	22.020	620	31.1.2024

What values and corporate philosophy does Cochlear represent?

Cochlear Ltd represents a strong set of values and corporate philosophy. The company is committed to improving the lives of people with hearing loss by providing innovative and reliable solutions. Cochlear believes in putting their customers first and delivering exceptional quality products and services. With a focus on continuous improvement, the company is dedicated to research and development to drive technological advancements in the field of hearing implants. Cochlear's corporate philosophy is centered around integrity, collaboration, and social responsibility. By embracing diversity and fostering a culture of inclusivity, Cochlear strives to make a positive impact on individuals and communities worldwide.

In which countries and regions is Cochlear primarily present?

Cochlear Ltd is primarily present in various countries and regions worldwide. The company operates in over 100 countries, including but not limited to Australia, the United States, Europe, Asia-Pacific, and Latin America. With its global presence, Cochlear Ltd has established itself as a leading provider of innovative hearing solutions and implantable hearing devices. Through its extensive network and collaborations, the company strives to enhance the lives of individuals with hearing loss across the world by providing advanced hearing technology and support.

What significant milestones has the company Cochlear achieved?

Cochlear Ltd has achieved several significant milestones. One of the notable milestones includes the development and introduction of the world's first commercially successful cochlear implant in 1982. This breakthrough technology revolutionized the treatment of hearing loss for millions of people worldwide. Another key milestone for Cochlear Ltd was the successful launch of the Nucleus 6 Sound Processor, which offered enhanced hearing performance and wireless connectivity options. The company also made significant progress in expanding its global footprint, establishing subsidiaries and partnerships in different regions. Additionally, Cochlear Ltd received numerous industry recognitions and awards for its innovative products and contribution to the field of hearing healthcare.

What is the history and background of the company Cochlear?

Cochlear Ltd is an Australian medical device company specializing in hearing implant solutions. Founded in 1981, it has a rich history and remarkable achievements in the field of implantable hearing devices. Cochlear is globally recognized for its groundbreaking advancements in the development and commercialization of cochlear implant technology. By providing solutions for people with profound hearing loss, Cochlear has improved the lives of millions worldwide. With a strong commitment to innovation and a dedicated team of experts, Cochlear remains at the forefront of the industry, continuously striving to enhance hearing experiences and transform lives through its state-of-the-art products and services.

Who are the main competitors of Cochlear in the market?

The main competitors of Cochlear Ltd in the market include major companies like Medtronic, Sonova Holding AG, and William Demant Holding A/S.

In which industries is Cochlear primarily active?

Cochlear Ltd is primarily active in the healthcare and medical device industries.

What is the business model of Cochlear?

Cochlear Ltd operates under a distinctive business model. As a global leader in the development and manufacturing of hearing solutions, the company primarily focuses on designing, producing, and marketing cochlear implant devices. Cochlear implants are electronic devices that provide a sense of sound to individuals with severe hearing loss or deafness. With a commitment to continuous innovation and superior quality, Cochlear Ltd offers a wide range of products and services that cater to the needs of patients, healthcare professionals, and hearing implant clinics worldwide. Through its robust business model, Cochlear Ltd aims to improve the lives of individuals with hearing challenges by providing cutting-edge and life-changing hearing solutions.

Hvilken P/E har Cochlear 2024?

Det Cochlear P/E-forhold er 54,08.

Hvad er KUV for Cochlear 2024?

Cochlear KUV er 9,36.

Hvilken AlleAktien kvalitetsscore har Cochlear?

AlleAktien Kvalitetsscore for Cochlear er 9/10.

Hvor høj er omsætningen for Cochlear 2024?

Den forventede Cochlear omsætning er 2,30 mia. AUD.

Hvor høj er overskuddet for Cochlear 2024?

Den forventede Cochlear indtjening er 397,99 mio. AUD.

Hvad laver Cochlear?

Cochlear Ltd is a leading provider of innovative medical solutions for people with hearing loss. The company is headquartered in Sydney, Australia and operates in over 100 countries worldwide. Cochlear specializes in imitating the functionality of the human ear to provide a better hearing experience for those with hearing loss. They offer a wide range of products and services including cochlear implants, audioprocessors, cochlear replacement parts, and hearing aids. Cochlear implants are one of the company's main products, designed to help those with severe to profound hearing loss regain their ability to hear. The implant is an electronic device that bypasses the inner ear by sending signals directly to the auditory nerve. In addition to cochlear implants and audioprocessors, Cochlear also offers wireless accessory devices such as TV streamers to enhance the listening experience. They have a dedicated department for manufacturing hearing aids called "Cochlear Devices," which are designed for individuals with mild to moderate hearing loss. The company is always working on new technologies to improve the listening experience for individuals with hearing loss, including their latest innovation, the Cochlear sound processor, which utilizes artificial intelligence to automatically adapt to different environments for optimal sound quality. Cochlear provides a range of services to support their customers, including training and support for healthcare professionals who implant or adjust Cochlear devices. They collaborate with customers, clinics, research institutions, and universities to develop the latest advancements in technology to improve the lives of individuals with hearing loss. Cochlear's business model is focused on promoting health and well-being, providing innovative hearing device and implant technologies, and comprehensive services to ensure an excellent patient experience. They are committed to playing a leading role in the treatment of hearing loss and helping people worldwide overcome their hearing challenges.

Hvor høj er Cochlear udbyttet?

Cochlear udbetaler et udbytte på 3,25 AUD fordelt over 2 udbetalinger om året.

Hvor ofte betaler Cochlear udbytte?

Cochlear udbetaler 2 gange om året en udbytte.

Hvad er Cochlear ISIN?

ISIN'en for Cochlear er AU000000COH5.

Hvad er den Cochlear WKN?

WKN for Cochlear er 898321.

Hvad er Cochlear tickeren?

Tickeren for Cochlear er COH.AX.

Hvor meget i udbytte betaler Cochlear?

I løbet af de sidste 12 måneder betalte Cochlear en dividende på 4,06 AUD . Dette svarer til et dividendeudbytte på omkring 1,24 %. For de kommende 12 måneder vil Cochlear sandsynligvis betale en dividende på 4,25 AUD.

Hvor høj er udbytteafkastet for Cochlear?

Udbytteafkastet for Cochlear er i øjeblikket 1,24 %.

Hvornår udbetaler Cochlear udbytte?

Cochlear betaler kvartalsvis udbytte. Dette uddeles i månederne oktober, april, oktober, april.

Hvor sikker er udbyttet fra Cochlear?

Cochlear betalte udbytte hvert år i løbet af de sidste 26 år.

Hvor høj er udbyttet fra Cochlear?

For de kommende 12 måneder forventes der dividender på 4,25 AUD. Dette svarer til et dividendeafkast på 1,30 %.

I hvilken sektor befinder Cochlear sig?

Cochlear bliver tildelt sektoren 'Sundhed'.

Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?

For at modtage det seneste udbytte på Cochlear fra den 15.4.2024 på 2,6 AUD, skulle du have haft aktien i din portefølje før ex-datoen den 21.3.2024.

Hvornår betalte Cochlear den seneste udbytte?

Udbetalingen af det sidste udbytte blev foretaget den 15.4.2024.

Hvor høj var udbyttet fra Cochlear i år 2023?

I løbet af 2023 udbetalte Cochlear 3,249 AUD i form af dividender.

I hvilken valuta udbetaler Cochlear udbyttet?

Udbytterne fra Cochlear udbetales i AUD.

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e
0,07	0,07	0,09	0,13	0,15	0,22	0,26	0,29	0,29	0,35	0,45	0,56	0,60	0,69	0,73	0,81	0,78	0,75	0,80	0,93	1,13	1,25	1,36	1,43	1,32	1,50	1,65	1,94	2,30	2,52	2,73	2,86	3,13	3,46
-	-1,37	27,78	39,13	14,06	52,05	15,32	13,28	-1,72	22,11	29,89	23,67	7,51	15,47	5,76	10,22	-3,71	-3,47	6,91	15,05	22,16	10,88	8,78	4,62	-7,43	13,41	10,09	17,48	18,75	9,61	8,21	4,91	9,47	10,44
-	-	-	-	74,66	67,12	71,48	77,24	73,33	73,85	71,02	71,20	72,38	72,19	73,30	72,56	74,45	72,61	69,40	71,35	71,95	71,99	73,73	75,88	74,55	73,35	75,85	75,05	-	-	-	-	-	-
0	0	0	0	0,11	0,15	0,18	0,22	0,21	0,26	0,32	0,40	0,44	0,50	0,54	0,59	0,58	0,55	0,56	0,66	0,81	0,90	1,01	1,08	0,98	1,10	1,25	1,45	0	0	0	0	0	0
13,00	15,00	18,00	25,00	31,00	46,00	52,00	80,00	52,00	80,00	108,00	153,00	165,00	177,00	225,00	246,00	220,00	182,00	154,00	215,00	270,00	324,00	348,00	359,00	241,00	355,00	394,00	411,00	527,00	600,00	672,00	727,00	776,00	0
17,81	20,83	19,57	19,53	21,23	20,72	20,31	27,59	18,25	22,99	23,89	27,37	27,45	25,50	30,65	30,41	28,24	24,20	19,15	23,24	23,89	25,86	25,53	25,18	18,26	23,71	23,91	21,23	22,92	23,81	24,64	25,41	24,78	-
10,00	10,00	13,00	16,00	20,00	31,00	40,00	58,00	36,00	54,00	80,00	100,00	115,00	130,00	155,00	180,00	56,00	132,00	93,00	145,00	188,00	223,00	245,00	276,00	-238,00	326,00	289,00	300,00	397,00	455,00	509,00	556,00	593,00	667,00
-	-	30,00	23,08	25,00	55,00	29,03	45,00	-37,93	50,00	48,15	25,00	15,00	13,04	19,23	16,13	-68,89	135,71	-29,55	55,91	29,66	18,62	9,87	12,65	-186,23	-236,97	-11,35	3,81	32,33	14,61	11,87	9,23	6,65	12,48
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
50,00	50,00	50,00	50,50	51,00	51,80	52,40	52,90	53,90	54,30	55,10	55,60	55,80	56,00	56,60	57,00	56,90	57,00	57,10	57,23	57,24	57,47	57,60	57,71	59,63	65,73	65,77	65,90	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	323,00	289,00	300,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	68,00	64,00	71,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35,00	45,00	-14,00
1,00	1,00	1,00	1,00	-2,00	1,00	-3,00	1,00	3,00	3,00	4,00	2,00	3,00	4,00	10,00	2,00	3,00	3,00	2,00	3,00	5,00	4,00	5,00	8,00	30,00	11,00	14,00	30,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-43,00	-7,00	23,00
0	0	0	0	0	0	-1,00	0	0	-2,00	-6,00	-8,00	-11,00	-9,00	-9,00	-6,00	-6,00	-7,00	-10,00	-7,00	-10,00	-8,00	-8,00	-5,00	-10,00	-12,00	-8,00	-9,00
-3,00	-4,00	-3,00	-8,00	-12,00	-16,00	-12,00	-17,00	-21,00	-19,00	-27,00	-56,00	-53,00	-46,00	-51,00	-50,00	-41,00	-39,00	-24,00	-32,00	-80,00	-78,00	-101,00	-90,00	-80,00	-14,00	-26,00	-79,00
19,00	6,00	14,00	25,00	11,00	19,00	0	78,00	49,00	98,00	51,00	76,00	84,00	146,00	179,00	201,00	168,00	69,00	111,00	188,00	185,00	259,00	258,00	296,00	-157,00	265,00	376,00	362,00
-1,00	-2,00	-2,00	-4,00	-5,00	-5,00	-17,00	-10,00	-13,00	-8,00	-15,00	-26,00	-29,00	-46,00	-92,00	-90,00	-37,00	-50,00	-31,00	-28,00	-37,00	-71,00	-49,00	-114,00	-130,00	-66,00	-77,00	-95,00
-4,00	-2,00	-2,00	-4,00	-5,00	-5,00	-17,00	-10,00	-13,00	-203,00	-14,00	-37,00	-39,00	-46,00	-92,00	39,00	-37,00	-50,00	-31,00	-28,00	-50,00	-135,00	-55,00	-137,00	-509,00	279,00	-138,00	-125,00
-3,00	0	0	0	0	0	0	0	0	-195,00	0	-10,00	-10,00	0	0	130,00	0	0	0	0	-12,00	-64,00	-5,00	-23,00	-379,00	346,00	-61,00	-29,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
2,00	0	0	0	-2,00	8,00	14,00	-8,00	10,00	176,00	-26,00	19,00	-25,00	16,00	-32,00	-93,00	2,00	106,00	67,00	-25,00	-20,00	26,00	-71,00	33,00	266,00	-421,00	-25,00	-72,00
0	0	0	0,00	0,00	0,00	0,00	0,01	0,03	0	0,02	0,00	0,01	0,01	0,02	0,00	0,00	-0,00	0	0	0,01	0,01	0	0,01	1,08	0,00	-0,00	-0,04
-0,00	-0,01	-0,01	-0,01	-0,02	-0,01	-0,00	-0,03	-0,00	0,13	-0,06	-0,04	-0,09	-0,06	-0,12	-0,21	-0,13	-0,04	-0,08	-0,15	-0,13	-0,11	-0,23	-0,14	1,15	-0,50	-0,22	-0,31
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2,00	-1,00	-10,00
-4,00	-6,00	-6,00	-8,00	-17,00	-18,00	-21,00	-33,00	-42,00	-42,00	-49,00	-60,00	-77,00	-89,00	-107,00	-118,00	-136,00	-142,00	-144,00	-123,00	-120,00	-143,00	-161,00	-181,00	-193,00	-75,00	-194,00	-197,00
34,00	7,00	23,00	47,00	13,00	43,00	-3,00	129,00	100,00	146,00	62,00	135,00	101,00	241,00	192,00	285,00	207,00	97,00	147,00	241,00	273,00	356,00	334,00	400,00	388,00	324,00	416,00	347,00
17,90	4,20	12,00	21,50	5,30	14,30	-16,20	68,30	35,70	90,60	36,60	50,40	55,40	99,90	87,10	110,80	130,90	19,30	79,50	160,27	147,56	188,70	208,40	181,40	-288,30	198,70	299,30	266,50
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Direkte emissioner	251
Indirekte emissioner fra indkøbt energi	8.693
Indirekte emissioner inden for værdikæden	1.046
CO₂-emissioner	8.944
CO₂-reduktionsstrategi	✅
Kulenergi	❌
Atomkraft	❌
Dyreforsøg	❌
Pels & Læder	—
Pesticider	—
Palm-Olie	—
Tobak	❌
Bioteknologi	❌
Klimakoncept	—
Bæredygtigt skovbrug	—
Genanvendelsesregler	❌
Miljøvenlig emballage	❌
Farlige stoffer	❌
Brændstofforbrug og -effektivitet	❌
Vandforbrug og -effektivitet	✅

Kvindelige ansattes andel	52
Kvindelig andel i ledelsen	—
Andel af asiatiske ansatte	—
Andel af asiatisk ledelse	—
Andel af hispano/latino-ansatte	—
Andel af hispano/latino-ledelse	—
Andel af sorte ansatte	—
Andel af sort ledelse	—
Andel af hvide ansatte	—
Andel af hvid ledelse	—
Voksenindhold	❌
Alkohol	❌
Våbenindustri	—
Skydevåben	❌
Hasardspil	❌
Militærkontrakter	❌
Menneskerettighedskoncept	✅
Databeskyttelseskoncept	—
Arbejds- og sundhedsbeskyttelse	✅
Katolsk	✅

Bæredygtighedsrapport	✅
Stakeholder-engagement	❌
Tilbagekaldelsespolitik	❌
Konkurrenceret	❌

Børs	Cochlear Ticker
ASX	COH.AX
DÜSSELDORF	OC5.DU
FRANKFURT	OC5.F
HAMBURG	OC5.HM
MÜNCHEN	OC5.MU
PNK	CHEOF
SIX	COH.SW

Cochlear Ticker	Cochlear FIGI
COH:AU	BBG000FT0MR1
COH:AT	BBG000FT0N80
OC5:GR	BBG000K9SM44
OC5:GF	BBG000K9SMQ0
OC5:GD	BBG000K9SN88
OC5:GS	BBG000K9SPJ1
OC5:GM	BBG000K9SQN4
OC5:GB	BBG000K9SR07
CHEOF:US	BBG000LSNP12
CHEOF:UV	BBG000LSR175
OC5:TH	BBG000TL2FZ7
COH:AH	BBG0027TW9J9
COH:SW	BBG006TLNTV5
COH:BW	BBG006TLNV13
COH2EUR:EO	BBG007PXSBS9
COH2EUR:XH	BBG007PXSBW4
COH2EUR:XF	BBG007PXSBY2
COH2EUR:XE	BBG007PXSC07
COH2EUR:XJ	BBG007PXSC16
COH2EUR:XL	BBG007PXSC25
COH2EUR:XG	BBG007PXSC34
COH2EUR:XO	BBG007PXSC43
COH2EUR:XS	BBG007PXSC89
COH2EUR:XA	BBG007PXSC98
COH2EUR:E1	BBG007PXSCB5
COH2EUR:XT	BBG007PXSCC4
COH2EUR:XW	BBG007PXSCD3
COH2EUR:XU	BBG007PXSCF1
COH2EUR:XV	BBG007PXSCH9
COH2EUR:EU	BBG007PXSCM3
OC5:QT	BBG008B72993
OC5:GZ	BBG00FGWG1G1
COH2EUR:XX	BBG00JN89NP8
COH2AUD:X2	BBG00JR8HLY9
COH2AUD:XB	BBG00JR8HLZ8
COH2AUD:XH	BBG00JR8HM13
COH2AUD:XF	BBG00JR8HM31
COH2AUD:XE	BBG00JR8HM59
COH2AUD:XJ	BBG00JR8HM68
COH2AUD:XL	BBG00JR8HM77
COH2AUD:XG	BBG00JR8HM86
COH2AUD:XO	BBG00JR8HM95
COH2AUD:XS	BBG00JR8HMF8
COH2AUD:XA	BBG00JR8HMG7
COH2AUD:E1	BBG00JR8HMH6
COH2AUD:XT	BBG00JR8HMJ4
COH2AUD:XW	BBG00JR8HMK2
COH2AUD:XU	BBG00JR8HML1
COH2AUD:XV	BBG00JR8HMM0
COH2AUD:XM	BBG00JR8HMN9
COH2AUD:XQ	BBG00JR8HMQ6
COH2AUD:XX	BBG00JR8HMR5
COH2AUD:XZ	BBG00JR8HMS4
COH2AUD:EU	BBG00JR8HMW9
COHN:PO	BBG00JRFXB22
COHN:L3	BBG00JRG1YG0
COHN:B3	BBG00JRG5LX5
COH2USD:XS	BBG00KMV3M55
COH2USD:XH	BBG00KMV3M82
COH2USD:XF	BBG00KMV3MB8
COH2USD:XE	BBG00KMV3MD6
COH2USD:XJ	BBG00KMV3MF4
COH2USD:XL	BBG00KMV3MG3
COH2USD:XG	BBG00KMV3MH2
COH2USD:XO	BBG00KMV3MJ0
COH2USD:XA	BBG00KMV3MN5
COH2USD:E1	BBG00KMV3MP3
COH2USD:XT	BBG00KMV3MQ2
COH2USD:XW	BBG00KMV3MR1
COH2USD:XU	BBG00KMV3MS0
COH2USD:XV	BBG00KMV3MT9
COH2USD:XM	BBG00KMV3MV6
COH2USD:XQ	BBG00KMV3MX4
COH2USD:XX	BBG00KMV3MY3
COH2USD:XZ	BBG00KMV3MZ2
COH2USD:EU	BBG00KMV3NG1
COHN:L1	BBG00Y7BP988
COHN:MM	BBG01255GWR0
COHN:MU	BBG01255GWT8
OC5:LA	BBG018H7NYB5
OC5:LU	BBG018J1B0S5

Gør de bedste investeringer i dit liv. fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Cochlear Aktie Aktieudbytte, Kurs, Prognose, Forum, Kursmål og Nyheder Cochlear ariva, Cochlear onvista, Cochlear finanzen.net, Cochlear aktienfinder, Cochlear marketscreener, Cochlear marketwatch, Cochlear bloomberg, Cochlear handelsblatt, Cochlear wiwo, Cochlear forum

Aktiekurs

Aktiekurs

TickerCOH.AX

ISINAU000000COH5

WKN898321

Cochlear Aktiens omsætning, EBIT, indtjening AU000000COH5 · 898321

Omsætning, Overskud & EBIT

Forståelse af Omsætning, EBIT og Indkomst

Årlig Analyse og Sammenligninger

Udnytte Forventninger til Investeringen

Investmentindsigter

Cochlear Omsætning, overskud og EBIT-historik

Cochlear Aktieparametre

GuV

Omsætning og vækst

Bruttomargin

EBIT og EBIT-margin

Indkomst og vækst

Udestående aktier

Fortolkning af årlig sammenligning

Forventninger og prognoser

Balance

Forståelse af balancen

Aktiver

Forpligtelser

Egenkapital

År-efter-år-analyse

Fortolkning af data

Cochlear Aktie Margener AU000000COH5 · 898321

Margen

Forståelse af bruttomargin

Analyse af EBIT-margin

Indsigt i omsætningsmargin

Fortolkning af forventninger

Sammenlignende analyse

Cochlear Margenhistorie

Cochlear Aktie Omsætning, EBIT, Indtjening per aktie AU000000COH5 · 898321

Omsætning, EBIT og indtjening per aktie

Omsætning per aktie

EBIT per aktie

Indkomst per aktie

Forventede værdier

Cochlear Omsætning, overskud og EBIT pr. aktie historik

Cochlear Aktie og aktieanalyse

Cochlear Vurdering ud fra historisk P/E, EBIT og P/S

Cochlear Antal Aktier AU000000COH5 · 898321

Omsætning, EBIT og indtjening per aktie

Omsætning per aktie

EBIT per aktie

Indkomst per aktie

Forventede værdier

Cochlear Aktieudbytte AU000000COH5 · 898321

Dividende

Oversigt over udbytter

Fortolkning og anvendelse

Investeringstrategi

Cochlear Udbyttehistorik

Cochlear Akties udbetalingsrate AU000000COH5 · 898321

Udbetalingsratio

Hvad er den årlige udbetalingsratio?

Sådan tolker du dataene

Brug af data til investeringer

Cochlear Udbetalingskvoteshistorik

Cochlear Indtjeningsforventninger

Cochlear Indtjenings overraskelser

Eulerpool ESG Rating for Cochlear-aktien

Eulerpool World ESG Rating (EESG©)

77/ 100

🌱 Environment

👫 Social

🏛️ Governance

Miljø (Environment)

Sociale (Social)

Virksomhedsledelse (Governance)

Cochlear Aktiens aktionærstruktur

Cochlear Bestyrelse og tilsynsråd

Hyppige spørgsmål om Cochlear-aktien

What values and corporate philosophy does Cochlear represent?

Gør de bedste investeringer i dit liv.
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Cochlear Aktie
Aktieudbytte, Kurs, Prognose, Forum, Kursmål og Nyheder Cochlear ariva, Cochlear onvista, Cochlear finanzen.net, Cochlear aktienfinder, Cochlear marketscreener, Cochlear marketwatch, Cochlear bloomberg, Cochlear handelsblatt, Cochlear wiwo, Cochlear forum

Ticker
COH.AX

ISIN
AU000000COH5

WKN
898321